Optimized viral dose and transient immunosuppression enable herpes simplex virus ICP0-null mutants To establish wild-type levels of latency in vivo (Q33806643)
scientific article
Language:
(P31) (Q13442814)
(P304) 5957-5967
(P407) (Q1860)
(P433) 13
(P478) 74
(P577) Saturday, July 1, 2000
(P921) (Q1455316)
(P1433) (Q1251128)
(P1476) "Optimized viral dose and transient immunosuppression enable herpes simplex virus ICP0-null mutants To establish wild-type levels of latency in vivo" (language: en)
(P2093) W P Halford
P A Schaffer
(P2860) (Q40898224)
(Q33798242)
(Q36367805)
(Q34487564)
(Q24523533)
(Q41074976)
(Q39880945)
(Q35889789)
(Q35888505)
(Q35886888)
(Q37364727)
(Q41158662)
(Q36824821)
(Q35865825)
(Q35860009)
(Q35854629)
(Q35855478)
(Q36655446)
(Q45780378)
(Q41337703)
(Q35848104)
(Q35849972)
(Q36376305)
(Q47725084)
(Q43515728)
(Q54473152)
(Q45732292)
(Q36831483)
(Q45845306)
(Q44357901)
(Q36829989)
(Q36829179)
(Q36780729)
(Q36782886)
(Q45851971)
(Q36688336)
(Q35319681)
(Q36687316)
(Q41624631)
(Q40065340)
(Q33931442)
(Q45714924)
(Q45748278)
(Q41049186)
(Q45769597)
(Q44975001)
(Q43527066)
(Q33864322)
(Q68481609)
(Q72069762)
(Q72279049)
(Q73026002)
(Q78203808)
other details
description scientific article

External Links